Login to Your Account

Financings Roundup

NewLink Prices IPO to Raise Up to $50M for Cancer Vaccine

By Catherine Shaffer
BioWorld Today Contributing Writer

Monday, November 14, 2011

After nearly a year of anticipation, NewLink Genetics Corp., of Ames, Iowa, priced its initial public offering of 6.2 million shares at $7 per share, with an underwriters' option of 930,000 additional shares. The offering could raise $49.9 million for the biotech, which specializes in cancer immunotherapeutics.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription